| 1 |
Almassinokiani F, Khodaverdi S, Solaymani-Dodaran M, et al. Effects of vitamin D on endometriosis-related pain: a double-blind clinical trial [J]. Med Sci Monit, 2016, 22: 4960-4966.
|
| 2 |
Nodler JL, DiVasta AD, Vitonis AF, et al. Supplementation with vitamin D or ω-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial [J]. Am J Clin Nutr, 2020, 112(1): 229-236.
|
| 3 |
Shaltout MF, Elsheikhah A, Maged AM, et al. A randomized controlled trial of a new technique for laparoscopic management of ovarian endometriosis preventing recurrence and keeping ovarian reserve [J]. J Ovarian Res, 2019, 12(1): 66.
|
| 4 |
Guo H, Li J, Shen X, et al. Efficacy of different progestins in women with advanced endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization-a single-center non-inferiority randomized controlled trial [J]. Front Endocrinol (Lausanne), 2020, 11: 129.
|
| 5 |
Morales-Prieto DM, Herrmann J, Osterwald H, et al. Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases [J]. Reprod Biol, 2018, 18(3): 252-258.
|
| 6 |
Osuga Y, Hayashi K, Kanda S. A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea [J]. Fertil Steril, 2020, 113(3): 627-635.
|
| 7 |
Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis [J]. Hum Reprod, 2014, 29(3): 400-412.
|
| 8 |
Mabrouk M, Paradisi R, Arena A, et al. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial [J]. Gynecol Endocrinol, 2018, 34(5): 399-403.
|
| 9 |
Morotti M, Sozzi F, Remorgida V, et al. Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment [J]. Eur J Obstet Gynecol Reprod Biol, 2014, 183: 188-192.
|
| 10 |
Yu Q, Zhou Y, Suturina L, et al. Efficacy and safety of estradiol valerate/dienogest for the management of heavy menstrual bleeding: a multicenter, double-blind, randomized, placebo-controlled, phase Ⅲ clinical trial [J]. J Womens Health (Larchmt), 2018, 27(10): 1225-1232.
|
| 11 |
Osuga Y, Hayashi K, Kanda S. Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea [J]. J Obstet Gynaecol Res, 2020, 46(4): 606-617.
|
| 12 |
Yu Q, Zhang S, Li H, et al. Dienogest for treatment of endometriosis in women: a 28-week, open-label, extension study [J]. J Womens Health (Larchmt), 2019, 28(2): 170-177.
|
| 13 |
Uysal G, Acmaz G, Madendag Y, et al. The efficacy of dienogest in the treatment of simple endometrial hyperplasia without atypia [J]. Gynecol Obstet Invest, 2018, 83(2): 151-155.
|
| 14 |
卢娜, 张丹, 苑文娜. 桂枝茯苓胶囊联合地诺孕素治疗子宫内膜异位症的临床研究 [J]. 现代药物与临床, 2020, 35(6).
|
| 15 |
徐冰, 李华军, 贾婉璐, 等. 地诺孕素用于难治性子宫内膜异位症疼痛的临床研究 [J]. 中华妇产科杂志, 2021, 56: 178-184.
|
| 16 |
Osuga Y, Fujimoto-Okabe H, Hagino A. Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study [J]. Fertil Steril, 2017, 108(4): 673-678.
|
| 17 |
Choi C, Kim WY, Lee DH, et al. Usefulness of hemostatic sealants for minimizing ovarian damage during laparoscopic cystectomy for endometriosis [J]. J Obstet Gynaecol Res, 2018, 44(3): 532-539.
|
| 18 |
黄婷, 黄高廷, 杨国敏, 等. 地诺孕素用于子宫内膜异位症保守术后维持治疗的Meta分析 [J]. 国际妇产科学杂志, 2021, 48(1): 26-34.
|